Our Story
Established in 2021, Lophos Pharma was founded by CEO Claire Stawnyczy, driven by the aspiration to provide environmentally conscious and ethically sourced plant-based psychedelics to individuals in need. In Canada, Peyote, scientifically known as lophophora williamsii, is legally accessible due to an exemption from the Controlled Drugs and Substances Act (CDSA). .
Our leadership team comprises individuals with diverse backgrounds from biotechnology, pharmaceutical manufacturing, food technology, quality assurance, and cybersecurity. This distinctive blend give us a unique perspective, paving the way for the responsible production of natural psychedelics for adult use.
Why Lophos
- We are North America’s largest cultivation and research facility for peyote cactus.
- Peyote cactus is legal to grow, sell, and consume in Canada through an exemption under the CDSA.
- By employing advanced cultivation methods, we aim to decrease the peyote growth timeline from 13 years to as low as 3 years.
- Backed by substantial expertise in pharmaceutical product manufacturing and controlled substance regulations, we skillfully navigate the intricacies of peyote cultivation and research.